LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Clinical trials for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED OR METASTATIC SOLID TUMORS trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED OR METASTATIC SOLID TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug enters first human trials
Disease control Recruiting nowThis is an early-stage study to test the safety and initial effectiveness of a new drug called RO7502175 for people with advanced solid tumors that have spread or cannot be cured. The drug will be tested both by itself and combined with other approved cancer drugs. The main goals…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New cancer drug MRG007 enters human testing for Tough-to-Treat tumors
Disease control Recruiting nowThis early-stage study is testing a new drug called MRG007 in people with advanced solid tumors that have spread and cannot be surgically removed. The main goals are to find a safe dose and see if the drug helps shrink tumors in patients with colorectal, gastric, pancreatic, and …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: ArriVent BioPharma, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
First patients receive experimental cancer drug in early safety trial
Disease control Recruiting nowThis is the first study in people to test a new drug called ANS014004 for advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and understand how the body processes the drug in about 63 adult participants. Researchers will a…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New targeted cancer drug enters Mid-Stage testing
Disease control Recruiting nowThis study is testing an experimental drug called YL202 in people with advanced solid tumors, including lung, colorectal, and cervical cancer, that have spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors and control the disease, and to unders…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New cancer drug trial seeks to control advanced tumors
Disease control Recruiting nowThis study is testing an experimental drug called YL202 in people with advanced solid tumors that have spread or can't be removed by surgery. The trial aims to see if YL202 can shrink tumors and control cancer growth while monitoring side effects. It will enroll 200 adults in Chi…
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE2 • Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
New hope for advanced cancer patients as experimental drug trial begins
Disease control Recruiting nowThis is the first study in people to test a new drug called XB010 for advanced solid tumors. The main goals are to find a safe dose and see how the body handles the drug, both by itself and when combined with another cancer therapy. It is for adults with certain advanced cancers …
Matched conditions: LOCALLY ADVANCED OR METASTATIC SOLID TUMORS
Phase: PHASE1 • Sponsor: Exelixis • Aim: Disease control
Last updated Feb 23, 2026 14:51 UTC